Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity

BackgroundSodium-glucose cotransporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP4i) are important second-line treatments for patients with type 2 diabetes mellitus (T2DM). Patients taking SGLT2i have favorable cardiovascular outcomes via various mechanisms, including autonomic...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jien-Jiun Chen, Chen Lin, Men-Tzung Lo, Lian-Yu Lin, Hsiang-Chih Chang, Geng-Chi Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2024-07-01
Colección:	Frontiers in Pharmacology
Materias:	NeuECG skin sympathetic nerve activity autonomic modulation entropy analysis sodium-glucose cotransporter 2 inhibitor
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1424544/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!